Virulence Genotype and Correlation of Clinical Severeness with Presence of the Type VI Secretion System in Klebsiella pneumoniae Isolates Causing Bloodstream Infections

References

• Zhou C, Wu Q, He L, et al. Clinical and molecular characteristics of carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates in a tertiary hospital in Shanghai, China. Infect Drug Resist. 2021;14:2697–2706. doi:10.2147/IDR.S321704
   PubMed Web of Science ®Google Scholar
• Ejaz H, Wang N, Wilksch JJ, et al. Phylogenetic analysis of Klebsiella pneumoniae from Hospitalized Children, Pakistan. Emerg Infect Dis. 2017;23(11):1872–1875. doi:10.3201/eid2311.170833
   Web of Science ®Google Scholar
• Heinz E, Ejaz H, Bartholdson Scott J, et al. Resistance mechanisms and population structure of highly drug resistant Klebsiella in Pakistan during the introduction of the carbapenemase NDM-1. Sci Rep. 2019;9(1):2392. doi:10.1038/s41598-019-38943-7
   PubMed Web of Science ®Google Scholar
• Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev. 2019;32(3):e00001–19. doi:10.1128/CMR.00001-19
   PubMed Web of Science ®Google Scholar
• Wang X, Xie Y, Li G, et al. Whole-genome-sequencing characterization of bloodstream infection-causing hypervirulent Klebsiella pneumoniae of capsular serotype K2 and ST374. Virulence. 2018;9(1):510–521. doi:10.1080/21505594.2017.1421894
   PubMed Web of Science ®Google Scholar
• Liu C, Guo J. Hypervirulent Klebsiella pneumoniae (hypermucoviscous and aerobactin positive) infection over 6 years in the elderly in China: antimicrobial resistance patterns, molecular epidemiology and risk factor. Ann Clin Microbiol Antimicrob. 2019;18(1):4. doi:10.1186/s12941-018-0302-9
   PubMed Web of Science ®Google Scholar
• Bei L, Zhao Y, Liu C, Chen Z, Zhou D. Molecular pathogenesis of Klebsiella pneumoniae. Future Microbiol. 2014;9(9):1071–1081. doi:10.2217/fmb.14.48
   Web of Science ®Google Scholar
• Hsu CR, Lin TL, Chen YC, Chou HC, Wang JT. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited. Microbiology. 2011;157(Pt 12):3446–3457. doi:10.1099/mic.0.050336-0
   PubMed Web of Science ®Google Scholar
• Russo TA, Shon AS, Beanan JM, et al. Hypervirulent K. pneumoniae secretes more and more active iron-acquisition molecules than ‘classical’ K. pneumoniae thereby enhancing its virulence. PLoS One. 2011;6(10):e26734. doi:10.1371/journal.pone.0026734
   Web of Science ®Google Scholar
• Russo TA, Olson R, Fang CT, et al. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol. 2018;56(9):e00776–18. doi:10.1128/JCM.00776-18
   PubMed Web of Science ®Google Scholar
• Li J, Ren J, Wang W, et al. Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections. Eur J Clin Microbiol Infect Dis. 2018;37(4):679–689. doi:10.1007/s10096-017-3160-z
   PubMed Web of Science ®Google Scholar
• Basler M, Pilhofer M, Henderson GP, Jensen GJ, Mekalanos JJ. Type VI secretion requires a dynamic contractile phage tail-like structure. Nature. 2012;483(7388):182–186. doi:10.1038/nature10846
   PubMed Web of Science ®Google Scholar
• Ho BT, Dong TG, Mekalanos JJ. A view to a kill: the bacterial type VI secretion system. Cell Host Microbe. 2014;15(1):9–21. doi:10.1016/j.chom.2013.11.008
   PubMed Web of Science ®Google Scholar
• Kudryashev M, Wang RY, Brackmann M, et al. Structure of the type VI secretion system contractile sheath. Cell. 2015;160(5):952–962. doi:10.1016/j.cell.2015.01.037
   PubMed Web of Science ®Google Scholar
• Silverman JM, Agnello DM, Zheng H, et al. Haemolysin coregulated protein is an exported receptor and chaperone of type VI secretion substrates. Mol Cell. 2013;51(5):584–593. doi:10.1016/j.molcel.2013.07.025
   PubMed Web of Science ®Google Scholar
• Pukatzki S, Ma AT, Sturtevant D, et al. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci USA. 2006;103(5):1528–1533. doi:10.1073/pnas.0510322103
   PubMed Web of Science ®Google Scholar
• Monjarás Feria J, Valvano MA. An overview of anti-eukaryotic T6SS effectors. Front Cell Infect Microbiol. 2020;10:584751. doi:10.3389/fcimb.2020.584751
   PubMed Web of Science ®Google Scholar
• Ma LS, Narberhaus F, Lai EM. IcmF family protein TssM exhibits ATPase activity and energizes type VI secretion. J Biol Chem. 2012;287(19):15610–15621. doi:10.1074/jbc.M111.301630
   Web of Science ®Google Scholar
• Bönemann G, Pietrosiuk A, Diemand A, Zentgraf H, Mogk A. Remodelling of VipA/VipB tubules by ClpV-mediated threading is crucial for type VI protein secretion. EMBO J. 2009;28(4):315–325. doi:10.1038/emboj.2008.269
   Web of Science ®Google Scholar
• Pietrosiuk A, Lenherr ED, Falk S, et al. Molecular basis for the unique role of the AAA+ chaperone ClpV in type VI protein secretion. J Biol Chem. 2011;286(34):30010–30021. doi:10.1074/jbc.M111.253377
   Web of Science ®Google Scholar
• Ma LS, Lin JS, Lai EM. An Icm F family protein, Imp LM, is an integral inner membrane protein interacting with Imp KL, and its walker a motif is required for type VI secretion system-mediated Hcp secretion in Agrobacterium tumefaciens. J Bacteriol. 2009;191(13):4316–4329. doi:10.1128/JB.00029-09
   Web of Science ®Google Scholar
• Murdoch SL, Trunk K, English G, Fritsch MJ, Pourkarimi E, Coulthurst SJ. The opportunistic pathogen Serratia marcescens utilizes type VI secretion to target bacterial competitors. J Bacteriol. 2011;193(21):6057–6069. doi:10.1128/JB.05671-11
   PubMed Web of Science ®Google Scholar
• Gallique M, Decoin V, Barbey C, et al. Contribution of the Pseudomonas fluorescens MFE01 type VI secretion system to biofilm formation. PLoS One. 2017;12(1):e0170770. doi:10.1371/journal.pone.0170770
   Web of Science ®Google Scholar
• Decoin V, Gallique M, Barbey C, et al. A Pseudomonas fluorescens type 6 secretion system is related to mucoidy, motility and bacterial competition. BMC Microbiol. 2015;15:72. doi:10.1186/s12866-015-0405-9
   Web of Science ®Google Scholar
• Spiewak HL, Shastri S, Zhang L, et al. Burkholderia cenocepacia utilizes a type VI secretion system for bacterial competition. Microbiologyopen. 2019;8(7):e774. doi:10.1002/mbo3.774
   Web of Science ®Google Scholar
• Joshi A, Kostiuk B, Rogers A, Teschler J, Pukatzki S, Yildiz FH. Rules of engagement: the type VI secretion system in Vibrio cholerae. Trends Microbiol. 2017;25(4):267–279. doi:10.1016/j.tim.2016.12.003
   PubMed Web of Science ®Google Scholar
• Manera K, Caro F, Li H, et al. Sensing of intracellular Hcp levels controls T6SS expression in Vibrio cholerae. Proc Natl Acad Sci USA. 2021;118(25):e2104813118. doi:10.1073/pnas.2104813118
   Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100. 29th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2019.
   Google Scholar
• Ejaz H, Younas S, Qamar MU, et al. Molecular epidemiology of extensively drug-resistant mcr encoded colistin-resistant bacterial strains co-expressing multifarious β-lactamases. Antibiotics. 2021;10(4):467. doi:10.3390/antibiotics10040467
   Web of Science ®Google Scholar
• Zhang X, Li F, Cui S, et al. Prevalence and distribution characteristics of blaKPC-2 and blaNDM-1 genes in Klebsiella pneumoniae. Infect Drug Resist. 2020;13:2901–2910. doi:10.2147/IDR.S253631
   Web of Science ®Google Scholar
• Ning Y, Hu R, Yao G, Bo S. Time to positivity of blood culture and its prognostic value in bloodstream infection. Eur J Clin Microbiol Infect Dis. 2016;35(4):619–624. doi:10.1007/s10096-016-2580-5
   PubMed Web of Science ®Google Scholar
• Cunha BA. Sepsis and septic shock: selection of empiric antimicrobial therapy. Crit Care Clin. 2008;24(2):313–34, ix. doi:10.1016/j.ccc.2007.12.015
   PubMed Web of Science ®Google Scholar
• Merritt JH, Kadouri DE, O’Toole GA. Growing and analyzing static biofilms. Curr Protoc Microbiol. 2005;2(1):1B.
   Google Scholar
• Shin J, Ko KS. Effect of plasmids harbouring blaCTX-M on the virulence and fitness of Escherichia coli ST131 isolates. Int J Antimicrob Agents. 2015;46(2):214–218. doi:10.1016/j.ijantimicag.2015.04.012
   Web of Science ®Google Scholar
• Weber BS, Miyata ST, Iwashkiw JA, et al. Genomic and functional analysis of the type VI secretion system in Acinetobacter. PLoS One. 2013;8(1):e55142. doi:10.1371/journal.pone.0055142
   PubMed Web of Science ®Google Scholar
• Shirley M. Ceftazidime-avibactam: a review in the treatment of serious gram-negative bacterial infections. Drugs. 2018;78(6):675–692. doi:10.1007/s40265-018-0902-x
   PubMed Web of Science ®Google Scholar
• Imtiaz W, Syed Z, Rafaque Z, Andrews SC, Dasti JI. Analysis of antibiotic resistance and virulence traits (genetic and phenotypic) in Klebsiella pneumoniae clinical isolates from Pakistan: identification of significant levels of carbapenem and colistin resistance. Infect Drug Resist. 2021;14:227–236. doi:10.2147/IDR.S293290
   Web of Science ®Google Scholar
• Ding Y, Wang H, Pu S, Huang S, Niu S. Resistance trends of Klebsiella pneumoniae causing urinary tract infections in Chongqing, 2011–2019. Infect Drug Resist. 2021;14:475–481. doi:10.2147/IDR.S295870
   Web of Science ®Google Scholar
• Qamar MU, Ejaz H, Walsh TR, et al. Clonal relatedness and plasmid profiling of extensively drug-resistant New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae clinical isolates. Future Microbiol. 2021;16:229–239. doi:10.2217/fmb-2020-0315
   Web of Science ®Google Scholar
• Liu L, Ye M, Li X, et al. Identification and characterization of an antibacterial type VI secretion system in the Carbapenem-resistant strain Klebsiella pneumoniae HS11286. Front Cell Infect Microbiol. 2017;7:442. doi:10.3389/fcimb.2017.00442
   PubMed Web of Science ®Google Scholar
• De oliveira Júnior NG, Franco OL. Promising strategies for future treatment of Klebsiella pneumoniae biofilms. Future Microbiol. 2020;15:63–79. doi:10.2217/fmb-2019-0180
   PubMed Web of Science ®Google Scholar
• Clegg S, Murphy CN, Mulvey MA, Stapleton AE, Klumpp DJ. Epidemiology and virulence of Klebsiella pneumoniae. Microbiol Spectr. 2016;4(1). doi:10.1128/microbiolspec.UTI-0005-2012
   PubMed Web of Science ®Google Scholar
• Mostafavi M, Wang L, Xie L, et al. Interplay of Klebsiella pneumoniae fabZ and lpxC mutations leads to LpxC inhibitor-dependent growth resulting from loss of membrane homeostasis. mSphere. 2018;3(5):e00508–18. doi:10.1128/mSphere.00508-18
   Web of Science ®Google Scholar
• Hood RD, Singh P, Hsu F, et al. A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe. 2010;7(1):25–37. doi:10.1016/j.chom.2009.12.007
   PubMed Web of Science ®Google Scholar
• MacIntyre DL, Miyata ST, Kitaoka M, Pukatzki S. The Vibrio cholerae type VI secretion system displays antimicrobial properties. Proc Natl Acad Sci USA. 2010;107(45):19520–19524. doi:10.1073/pnas.1012931107
   PubMed Web of Science ®Google Scholar